Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 12:05 AM
NCT ID:
NCT03253458
Eligibility Criteria:
Inclusion criteria
* age ≥ 18 years
* signed informed consent
* mpMRI data available
Exclusion criteria
* Patients with a known allergic reaction to fluorescein cannot participate in this study.
* Documented acute prostatitis or urinary tract infections
* No ability to stop anticoagulant or antiplatelet therapy
* Medical history of a bleeding disorder or if available platelet Count \<140/uL, prothrombin time \>14.5 sec., partial thromboplastin time \>34 sec.
* Major concurrent debilitating illness or ASA ≥4
* Biological or chemotherapy for PCa
* Hormonal therapy within last six months
* Has any medical condition or other circumstances which would significantly decrease the chances of obtaining reliable data, achieving study objectives, or completing the study
* Is incapable of understanding the language in which the information for the patient is given
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT03253458
Study Brief:
Protocol Section:
NCT03253458